PAPER Hans S, Stanton JE, Sauer AK, Shiels K, Saha SK, Lordan R, Tsoupras A, Zabetakis I, Grabrucker AM
SEARCH RESULTS
331178 RESULTS
Suzanne Schindler on Could New Alzheimer’s Marker p-Tau212 Rival p-Tau217?
COMMENT Kac and colleagues validated an immunoassay for plasma p-Tau212 in multiple clinical and autopsy cohorts. They demonstrated that their p-Tau212 antibody does not cross-react with p-Tau217. However, the results for their plasma p-Tau212 and p-Tau217 assays
Could New Alzheimer’s Marker p-Tau212 Rival p-Tau217?
RESEARCH NEWS 2024-04-20 Research News Among plasma biomarkers for Alzheimer’s disease, p-Tau217 stands tall as having the highest diagnostic accuracy. Now, in the March 23 Nature Communications, researchers led by Przemyslaw Kac, Thomas Karikari, and Kaj Blennow at the Universit
PAPER Li X, Bai J, Guo X, Mu Y, Di Z, Zhang G, Wang B, Zhang Y, Liu X, Shi Y, Lin S, Wu L, Bai Y, Liu X
Identifying New Subtypes of Multiple System Atrophy Using Cluster Analysis.
J Parkinsons Dis. 2024 Apr 12; PubMed: 38640168PAPER Carlsson A, Axell E, Emanuelsson C, Olsson U, Linse S
The Ability of DNAJB6b to Suppress Amyloid Formation Depends on the Chaperone Aggregation State.
ACS Chem Neurosci. 2024 Apr 19; PubMed: 38640082PAPER Welton T, Teo TW, Chan LL, Tan EK, Tan LC
Parkinson's Disease Risk Variant rs9638616 is Non-Specifically Associated with Altered Brain Structure and Function.
J Parkinsons Dis. 2024 Apr 12; PubMed: 38640170PAPER Rubin R
Could GLP-1 Receptor Agonists like Semaglutide Treat Addiction, Alzheimer Disease, and Other Conditions?
JAMA. 2024 Apr 19; PubMed: 38639975PAPER Das S
Omics Approaches in Alzheimer's Disease Research.
J Alzheimers Dis. 2024 Apr 16; PubMed: 38640162PAPER Hao X, Abeysinghe R, Zheng F, Schulz PE, Alzheimer’s Disease Neuroimaging Initiative, Cui L
Mapping of Alzheimer's disease related data elements and the NIH Common Data Elements.
BMC Med Inform Decis Mak. 2024 Apr 19;24(Suppl 3):103. PubMed: 38641585PAPER
Erratum to: Ubiquitin Specific Protease 13 Regulates Tau Accumulation and Clearance in Models of Alzheimer's Disease.
J Alzheimers Dis. 2024;98(4):1543-1546. PubMed: 38640189PAPER Lee CH, Saw JE, H-L Chen E, Wang CH, Uchihashi T, P-Y Chen R
The positively charged cluster in the N-terminal disordered region may affect prion protein misfolding: Cryo-EM structure of hamster PrP(23-144) fibrils.
J Mol Biol. 2024 Apr 17;:168576. PubMed: 38641239PAPER Jiang S, Sydney EJ, Runyan AM, Serpe R, Srikanth M, Figueroa HY, Yang M, Myeku N
5-HT4 receptor agonists treatment reduces tau pathology and behavioral deficit in the PS19 mouse model of tauopathy.
Front Cell Neurosci. 2024;18:1338502. Epub 2024 Apr 4 PubMed: 38638303PAPER Nabizadeh F, Pirahesh K, Aarabi MH, Wennberg A, Pini L
Behavioral and dysexecutive variant of Alzheimer's disease: Insights from structural and molecular imaging studies.
Heliyon. 2024 Apr 30;10(8):e29420. Epub 2024 Apr 9 PubMed: 38638964PAPER Cao L, Han K, Lin L, Hing J, Ooi V, Huang N, Yu J, Ng TK, Feng L, Mahendran R, Kua EH, Bao Z
Reversal of the concreteness effect can be detected in the natural speech of older adults with amnestic, but not non-amnestic, mild cognitive impairment.
Alzheimers Dement (Amst). 2024;16(2):e12588. Epub 2024 Apr 18 PubMed: 38638800PAPER Sighinolfi G, Mitolo M, Pizzagalli F, Stanzani-Maserati M, Remondini D, Rochat MJ, Cantoni E, Venturi G, Vornetti G, Bartiromo F, Capellari S, Liguori R, Tonon C, Testa C, Lodi R
Sulcal Morphometry Predicts Mild Cognitive Impairment Conversion to Alzheimer's Disease.
J Alzheimers Dis. 2024 Apr 17; PubMed: 38640154Current Filters
No filters selected